<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Vasile Foca on Medium]]></title>
        <description><![CDATA[Stories by Vasile Foca on Medium]]></description>
        <link>https://medium.com/@vasilefoca?source=rss-2a703d446a1e------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*EGQld7nGDENl7auYcplK6g.jpeg</url>
            <title>Stories by Vasile Foca on Medium</title>
            <link>https://medium.com/@vasilefoca?source=rss-2a703d446a1e------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 19:13:08 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@vasilefoca/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[DARKTRACE IPO: A CORNERSTONE EVENT FOR BRITISH TECH]]></title>
            <link>https://medium.com/@vasilefoca/darktrace-ipo-a-cornerstone-event-for-british-tech-74c35076331c?source=rss-2a703d446a1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/74c35076331c</guid>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[darktrace]]></category>
            <category><![CDATA[scaleup]]></category>
            <category><![CDATA[talis-capital]]></category>
            <category><![CDATA[ipo]]></category>
            <dc:creator><![CDATA[Vasile Foca]]></dc:creator>
            <pubDate>Sat, 08 May 2021 14:33:12 GMT</pubDate>
            <atom:updated>2021-05-08T14:33:12.232Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/605/1*oJ88EpY_fIDqTSo9UHzh9Q.jpeg" /></figure><p>As Darktrace went <a href="https://www.londonstockexchange.com/stock/DARK/darktrace-plc/company-page">public on the London Stock Exchange </a>on 30th of April it cemented its status as one of the most successful cybersecurity companies in the world. Needless to say, this is a huge boost for the UK’s tech sector — as well as being a monumental moment for Talis, as it marks the first company in our portfolio to go public. It’d be an understatement to say that I, and the Talis team, are hugely proud of Poppy and the Darktrace team’s commitment to their mission — as well as their impeccable execution in building the company to be the cybersecurity juggernaut that it is today.</p><p>Darktrace — which achieved unicorn status in 2018 — has been long-acclaimed as a UK tech success story, widely cited for not only for its incredible pace of growth, its industry-defining standards for gender equality (with a 40% female employee base globally) but also the pivotal role it has played in protecting the public. In 2016, shortly after the company had coined its ‘machine-fights-back’ technology, the infamous WannaCry attack occurred, a fast-moving form of ransomware: Darktrace’s deployment in NHS trusts in the UK enabled quick action to, quite literally, save lives. The company also was hailed for its response to the Chinese nation state attack of March 2020 — named PT41 — which was a monumental moment for cyber AI technology as it flagged a ‘zero day’ attack (a never-seen-before cyber attack) two full weeks before any human analysts.</p><p>While the company has seen rapid growth over the past eight years — now boasting a remarkable roster of over 4,000 clients worldwide, employing 1,500 in 44 office locations — the company had somewhat humbler beginnings. We were first introduced to the company in 2013: at the time, Darktrace was a small team of six, world-class mathematicians from the University of Cambridge, who were experimenting with how to help machines learn a sense of self. Poppy Gustafsson, Nicole Eagan, Jack Stockdale, Emily Orton and Dave Palmer — the company’s founders, who still lead the business to this day — had partnered with the former cyber experts at the UK’s GCHQ to help to resolve their frustrations around cyber attackers who had been winning too many battles.</p><p>We’d started looking at the cybersecurity space in 2011, but we were keen to see alternatives to what was in the market already, which was largely made up of endpoint security solutions, perimeter defence, next-gen firewalls, email security tools and some security incident and event management solutions. The common denominator with every product on the market at the time was that they were all focusing on outside-in defence: and at that time, some of the biggest cyber attacks in history like Yahoo, eBay and Sony had been a result of insider threats. We were looking for a company that was taking a fundamentally different approach to the problem.</p><p>Darktrace stood out from its perceived competitors. If others were trying to use machine learning, or they were planning to use artificial intelligence, most of them were supervised. Darktrace was the first company to actually showcase and prove that it could use unsupervised machine learning that learns as it goes: which, at the time, was a completely revolutionary approach to AI in cybersecurity.</p><p>It’s really not every day you meet founders like Poppy and the team. While they’ve all grown as leaders over the past few years, it was clear they were serious about their mission when we met to discuss leading their Series A in 2015. Frankly, the company didn’t feel like a startup then. With some founders, you’re solely buying into their passion, vision and drive when you invest: with Darktrace, they paired their passion and vision with world-class experience. Nicole, for example, was bringing over 20 years’ worth of experience of closing large enterprise sales contracts, close to $100m, with the likes of Oracle. At this stage of their journey, they’d taken on Drax, the UK’s largest utility company, as their client which speaks volumes for a pre-Series A startup. They also had a world-class advisory board guiding them through the development of their innovation, which enabled massive opportunities for the company early on.</p><p>The integration of AI within cybersecurity has become a necessity in recent years: Poppy predicts that cyber criminals will imminently get their hands on this kind of AI innovation, and as a result, the world is going to see highly targeted and specific attacks that require the most comprehensive technology to fight back. The COVID era has also only highlighted the necessity for the highest level of protection of IT infrastructure which now must extend to and protect every individual’s home office.</p><p>The company’s IPO is a landmark event for the London Stock Exchange and the British technology sector, paving a new path for flourishing tech companies to follow in their footsteps.<strong> </strong>London was the natural choice for Darktrace’s IPO listing: the company’s roots are in Cambridge and its heritage is deeply embedded within the country’s thriving security sector. While in some ways today’s news marks the end of a chapter for Darktrace, we know that they’re just getting started. Darktrace has never followed the status quo and will continue to forge its own future as a publicly listed company, and it’s absolutely our pleasure to support Poppy and the team in the next phase of this monumental journey.</p><p>Vasile</p><p>Read more on the news:</p><p><a href="https://www.ft.com/content/325059d4-a24c-4d4c-9fdb-0214179fc822">Darktrace shares jump 40% in IPO</a>, Financial Times</p><p><a href="https://www.businessinsider.com/darktrace-shares-soar-38-following-its-ipo-in-london-2021-4?IR=T&amp;r=US">Cybersecurity firm Darktrace floats at $2.37 billion valuation as shares soar 38% in early trading</a>, Business Insider</p><p><a href="https://www.bloomberg.com/news/articles/2021-04-30/darktrace-s-230-million-u-k-ipo-prices-in-middle-of-range?sref=1BSaVdRU">Darktrace Shares Surge 44% in Trading Debut After London IPO</a>, Bloomberg</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=74c35076331c" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[A remedy to count on!]]></title>
            <link>https://medium.com/@vasilefoca/a-remedy-to-count-on-ab0cea7837a5?source=rss-2a703d446a1e------2</link>
            <guid isPermaLink="false">https://medium.com/p/ab0cea7837a5</guid>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[startup]]></category>
            <dc:creator><![CDATA[Vasile Foca]]></dc:creator>
            <pubDate>Mon, 29 Apr 2019 09:21:57 GMT</pubDate>
            <atom:updated>2019-04-29T09:21:57.579Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>Medbelle is Talis Capital’s first investment in healthtech and we are very proud to be joining signals Venture Capital, Mutschler Ventures, IBB and Cavalry Ventures in contributing to the Berlin-based company’s $7m Series A fundraise.</strong></p><p>As my colleague Beatrice has explained in great detail, in a two-part<a href="https://www.taliscapital.com/research/2019/jan/healthcare/digitaljourney"> blog</a>, digital disruption of healthcare is well underway, particularly here in the UK. We see <strong>healthtech as a key sector for future investment </strong>and within that very broad sector, we have identified several sub-verticals as ripe for transformation including telemedicine and digital hospitals.</p><p>Medbelle is a digital hospital that fits exactly into that thesis. It offers services through a digital platform that has the potential to both improve the patient experience dramatically, as well as create much-needed efficiencies in the way services and procedures are provided.</p><p>Medbelle offers self-pay customers a way to find and connect with doctors, putting them in control of their care. So far, c.800 procedures have been booked through Medbelle — a number which is expected to soar as it begins to expand its offer.</p><p>Patients can book their procedure through Medbelle, which provides them with leading specialists and state-of-the-art operating facilities. All of the organisation is taken care of by the platform. Interactions between the patient and their support team take place between a single simple web portal and app.</p><p>All of this is revolutionary from the point of view of the patient. Navigating private health care can be tricky and prospective patients can often feel overwhelmed, even deterred, by the sheer number of specialists out there and the complexity of the subject, and need to get it right.</p><p>One of the themes that we at Talis Capital see across many verticals is information overload and the increasing desire from consumers for expert advice and guidance. People are daunted by the huge range of choice the internet puts at their fingertips — especially in complex fields like healthcare — and we are seeing a shift from aggregation — you could see as the Amazon or Ebay model — to curation. (In travel, this is a key theme and the reason we invested in <a href="https://www.plumguide.com/">The Plum Guide</a>.)</p><p>In Medbelle the platform can educate the patient, explain the procedure, connect them with the right surgeon and book the operation. There is transparency around pricing — no need for essential costs to be overlooked — and the whole patient journey, from consultation to post-procedure check ups, can be managed.</p><p>From a provider point of view, Medbelle also provides a new way to maximise expensive facilities. It can help to utilize underused operating theatres and make sure highly-trained surgeons use their time well.</p><p><strong>Medbelle is solving pain points on both sides of the patient journey.</strong></p><p>To achieve this, the German-founded company is devoted to attracting the top echelon of doctors and specialists. For instance, all its surgeons are Fellows of the Royal College of Surgeons and registered as a specialist in the General Medical Council amongst a number of other qualifications, which means that patients can be assured that they are in safe hands.</p><p>We truly believe that this will be a groundbreaking service in patient care. From a start in the self-pay market, it has the potential to accelerate growth, especially with increasing opportunities to work with the NHS and health insurers.</p><p><strong>Which brings us to the co-founders of Medbelle — Daniel Kolb and Leander de Laporte. </strong>They’re both great entrepreneurs with a passion for creating a truly innovative healthcare business.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/450/1*tg4cwwEteGYNDSpwgjdLvQ.jpeg" /><figcaption>Medbelle Co Founders</figcaption></figure><p>Leander saw it in first person looking at the doctors in his own family, and understood the problem of inefficiencies from a doctor and a patient perspective.</p><p>We were convinced of both their business case and their capability to do it. The fact that they had track-record scaling startups, was doubly reassuring.</p><p>Sometimes it takes 12 months or even longer to be sure that you want to invest in a company. Having researched the digital health sector for over 2 years — we know the types of companies we’re looking for. We found and invested in Medbelle in a very short time and have real conviction as well as great excitement in the deal.</p><p><strong>Medbelle may be our first investment in health tech but we are certain we are in safe hands!</strong></p><p>ENDS</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ab0cea7837a5" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>